Anish Bhatnagar — SEC Form 4 filings
SEC reporting owner CIK 1614821. 13 Form 4 filings on record with FilingPulse; latest filed 2026-05-18.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-01-29 to 2026-05-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 31 legs across 8 filings — 1,024,930 shares, $62,274,728 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 31.
- Largest priced transaction: sale of 209,689 shares @ $66.33 ($13,908,797) in SOLENO THERAPEUTICS INC, filed 2025-03-31.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| SOLENO THERAPEUTICS INC (SLNO) | CHIEF EXECUTIVE OFFICER, Director | 13 | — | 31 legs · 1,024,930 sh · $62,274,728 | 31 |
Form 4 filings — Anish Bhatnagar
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-18 | 4 | SOLENO THERAPEUTICS INC (SLNO) | Disposition to issuer (D): 583,656 · Disposition to issuer (D): 22,452 (derivative) · Disposition to issuer (D): 60 (derivative) · Disposition to issuer (D): 23,332 (derivative) · Disposition to issuer (D): 35,000 (derivative) · Disposition to issuer (D): 8,473 (derivative) · +6 more | EDGAR |
| 2026-01-23 | 4 | SOLENO THERAPEUTICS INC (SLNO) | Grant/award (A): 114,200 @ $0 · Grant/award (A): 131,400 (derivative) @ $0 | EDGAR |
| 2025-12-17 | 4 | SOLENO THERAPEUTICS INC (SLNO) | Tax withholding (F): 7,620 @ $49.95 · Gift (G): 100,000 @ $0 | EDGAR |
| 2025-03-31 | 4 | SOLENO THERAPEUTICS INC (SLNO) | Sale (S): 14,183 @ $65.97 · Sale (S): 23,095 @ $66.79 · Sale (S): 41,989 @ $67.70 · Sale (S): 55,234 @ $68.79 · Sale (S): 31,980 @ $69.84 · Sale (S): 3,291 @ $70.73 · +18 more | EDGAR |
| 2025-01-23 | 4 | SOLENO THERAPEUTICS INC (SLNO) | Grant/award (A): 53,900 @ $0 · Grant/award (A): 115,600 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | SOLENO THERAPEUTICS INC (SLNO) | Sale (S): 10,077 @ $45.37 · Sale (S): 860 @ $45.92 · Sale (S): 10,154 @ $46.18 | EDGAR |
| 2024-10-03 | 4 | SOLENO THERAPEUTICS INC (SLNO) | Sale (S): 19,413 @ $49.34 · Sale (S): 2,220 @ $50.25 | EDGAR |
| 2024-08-30 | 4 | SOLENO THERAPEUTICS INC (SLNO) | Sale (S): 30,262 @ $47.19 · Sale (S): 26,351 @ $48.03 · Sale (S): 47,551 @ $47.16 · Sale (S): 10,840 @ $47.83 | EDGAR |
| 2024-08-07 | 4 | SOLENO THERAPEUTICS INC (SLNO) | Sale (S): 32,789 @ $45.48 · Sale (S): 25,424 @ $46.14 · Sale (S): 6,789 @ $43.64 · Sale (S): 22,937 @ $45.25 · Sale (S): 39,405 @ $45.89 | EDGAR |
| 2024-07-19 | 4 | SOLENO THERAPEUTICS INC (SLNO) | Grant/award (A): 850,000 @ $0 | EDGAR |
| 2024-07-03 | 4 | SOLENO THERAPEUTICS INC (SLNO) | Sale (S): 4,198 @ $41.22 · Sale (S): 15,058 @ $41.63 | EDGAR |
| 2024-04-03 | 4 | SOLENO THERAPEUTICS INC (SLNO) | Sale (S): 11,383 @ $41.12 · Sale (S): 7,597 @ $41.67 | EDGAR |
| 2024-01-29 | 4 | SOLENO THERAPEUTICS INC (SLNO) | Sale (S): 2,527 @ $48.30 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1614821 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →